Today: 21 May 2026
Exxon Mobil stock slips today as oil heads for biggest annual drop since 2020
31 December 2025
2 mins read

Exxon Mobil stock slips today as oil heads for biggest annual drop since 2020

NEW YORK, December 31, 2025, 14:11 ET — Regular session.

  • Exxon Mobil shares were down about 0.6% in afternoon trading as crude prices drifted lower.
  • A U.S. government report showed a draw in crude inventories but big builds in gasoline and diesel stocks, clouding the near-term demand picture.
  • Investors are watching the Jan. 4 OPEC+ meeting and late-January corporate earnings for fresh direction.

Exxon Mobil (XOM) shares edged lower on Wednesday, down 0.6% at $120.22 in afternoon trade, after moving between $119.87 and $121.49.

The muted move still mattered on the final trading day of the year, with oil prices on track for their steepest annual decline since 2020 and investors recalibrating expectations for 2026 cash flow across the sector.

For integrated oil majors like Exxon, small changes in crude prices and refinery profitability can swing sentiment quickly, especially in holiday-thinned trading when liquidity is lighter.

Brent crude, the global benchmark, was hovering near $61 a barrel, while U.S. West Texas Intermediate (WTI) crude was around $58, Reuters reported. Oil is headed for a drop of more than 15% in 2025 as oversupply worries built, even amid geopolitical risk, and the OPEC+ producer group is due to meet on Jan. 4. Reuters also cited a BNP Paribas forecast for Brent to dip to $55 a barrel in the first quarter before recovering to around $60 for the rest of 2026.

In the U.S., the Energy Information Administration said crude inventories fell by 1.9 million barrels last week, but gasoline stocks rose by 5.8 million barrels and distillate stockpiles — which include diesel and heating oil — climbed 5 million barrels. “Year-end numbers tend to be distorted … less meaningful,” said Josh Young, chief investment officer at Bison Interests, pointing to ad valorem taxes — levies tied to inventory value — that can prompt companies to reduce stored crude at year-end. Reuters

For Exxon, those crosscurrents are key because it produces oil and gas and also runs large refining and fuels businesses. Refining margins — the gap between fuel prices and crude costs — help determine whether lower crude is a tailwind or a headwind for downstream earnings.

Other oil majors were also mixed to lower. Chevron was little changed, while U.S.-listed shares of Shell and BP fell about 0.5% and 0.1%, respectively.

Traders are likely to keep focusing on whether post-holiday fuel demand holds up, with weekly inventory data and refinery utilization offering near-term signals for both crude and product markets.

Rates remain another variable. The Federal Reserve’s next policy meeting is scheduled for Jan. 27-28, and investors currently expect the central bank to leave its benchmark rate unchanged, Reuters reported.

Exxon has leaned on long-cycle, low-cost developments and efficiency efforts to support returns through commodity swings. The company said this month it raised its 2030 plan, targeting $25 billion in earnings growth from 2024 through 2030 without increasing capital spending.

On the calendar, earnings are the next major Exxon-specific catalyst. Earnings calendars on Yahoo Finance list Exxon as expected to report fourth-quarter results on Jan. 30, before the market opens.

With U.S. markets closed on New Year’s Day, investors heading into the close were watching oil’s year-end settle and the demand signals embedded in fuel inventories for clues on how energy shares may start 2026.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop